联想创投再加注！被投企业“智冉医疗”完成3亿元A+轮融资｜LCIG Portfolio

联想创投02-11

近日，联想创投被投企业——国内侵入式脑机接口领军企业智冉医疗宣布完成3亿元人民币A+轮融资。本轮融资由中科创星领投，老股东联想创投、君联资本、北京市医药健康产业投资基金、IDG资本、顺为资本、元生创投、红杉中国、美团龙珠、BV百度风投、杏泽资本、佳银资本持续跟投。值得关注的是，这是智冉医疗在半年内完成的第二轮融资，短时间内连续获得资本青睐，充分印证了市场对其在侵入式脑机接口赛道技术实力与发展潜力的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2610601380?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-11 10:29","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2610601380","market":"hk","top_or_hot":-1,"title":"联想创投再加注！被投企业“智冉医疗”完成3亿元A+轮融资｜LCIG Portfolio","media":"联想创投","content":"<div>\n<p>近日，联想创投被投企业——国内侵入式脑机接口领军企业智冉医疗宣布完成3亿元人民币A+轮融资。本轮融资由中科创星领投，老股东联想创投、君联资本、北京市医药健康产业投资基金、IDG资本、顺为资本、元生创投、红杉中国、美团龙珠、BV百度风投、杏泽资本、佳银资本持续跟投。值得关注的是，这是智冉医疗在半年内完成的第二轮融资，短时间内连续获得资本青睐，充分印证了市场对其在侵入式脑机接口赛道技术实力与发展潜力的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021110555297a5b8eb&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>联想创投再加注！被投企业“智冉医疗”完成3亿元A+轮融资｜LCIG Portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n联想创投再加注！被投企业“智冉医疗”完成3亿元A+轮融资｜LCIG Portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-11 10:29 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021110555297a5b8eb&s=b><strong>联想创投</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，联想创投被投企业——国内侵入式脑机接口领军企业智冉医疗宣布完成3亿元人民币A+轮融资。本轮融资由中科创星领投，老股东联想创投、君联资本、北京市医药健康产业投资基金、IDG资本、顺为资本、元生创投、红杉中国、美团龙珠、BV百度风投、杏泽资本、佳银资本持续跟投。值得关注的是，这是智冉医疗在半年内完成的第二轮融资，短时间内连续获得资本青睐，充分印证了市场对其在侵入式脑机接口赛道技术实力与发展潜力的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021110555297a5b8eb&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0052756011.USD","symbol_name":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021110555297a5b8eb&s=b","article_id":"2610601380","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021110555297a5b8eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2610601380","pubTimestamp":1770776985,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近日，联想创投被投企业——国内侵入式脑机接口领军企业智冉医疗宣布完成3亿元人民币A+轮融资。值得关注的是，这是智冉医疗在半年内完成的第二轮融资，短时间内连续获得资本青睐，充分印证了市场对其在侵入式脑机接口赛道技术实力与发展潜力的双重认可。临床进展2025年，智冉医疗已完成国内首例超百通道侵入式脑机接口产品的临床植入，初步验证了产品的安全性和有效性。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"80992":"联想集团-R","LU0052756011.USD":"TEMPLETON GLOBAL BALANCED \"A\" (USD) INC","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0264606111.USD":"Janus Henderson Horizon Asian Dividend Income A2 USD","LU0310800965.SGD":"FTIF - Templeton Global Balanced A Acc SGD","00992":"联想集团","IE0032431581.USD":"PINEBRIDGE GREATER CHINA EQUITY \"A\" (USD) ACC","LU1366334651.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"I\" (USD) INC","IE0034224299.USD":"PINEBRIDGE ASIA EX JAPAN EQUITY \"A\" (USD) ACC","LU0049112450.USD":"FIDELITY PACIFIC \"A\" INC","LU1366334578.USD":"ALLSPRING EMERGING MARKETS EQUITY INCOME \"A\" (USD) INC","LNVGY":"联想集团ADR","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","BK1193":"电脑硬件、储存设备及电脑周边","LU0572939691.SGD":"Janus Henderson Horizon Asian Dividend Income A2 SGD","LU1235295612.USD":"FIDELITY PACIFIC \"A\" (USDHDG) INC","LU0791590937.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"A\" (USD)","LU0791591158.USD":"ALLSPRING  EMERGING MARKTES EQUITY INCOME \"I\" (USD) ACC","IE00B0JY6N72.USD":"PINEBRIDGE GLOBAL EMERGING MARKETS FOCUS EQUITY \"A\" (USD) ACC","BK1526":"科网股","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","LU1267930227.SGD":"TEMPLETON GLOBAL BALANCED \"AS\" (SGD) ACC A","BK1607":"新IT概念","LU0572940350.SGD":"Janus Henderson Horizon Asian Dividend Income A3 SGD","LU1046422090.SGD":"Fidelity Pacific A-SGD","LU0128525689.USD":"TEMPLETON GLOBAL BALANCED \"A\"(USD) ACC","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC"},"translate_title":"Lenovo Venture Capital raises another bet! The invested company \"Zhiran Medical\" completed 300 million yuan in Series A + financing | LCIG Portfolio","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"80992":0.9,"LNVGY":0.6,"00992":1.5},"content_text":"近日，联想创投被投企业——国内侵入式脑机接口领军企业智冉医疗宣布完成3亿元人民币A+轮融资。本轮融资由中科创星领投，老股东联想创投、君联资本、北京市医药健康产业投资基金、IDG资本、顺为资本、元生创投、红杉中国、美团龙珠、BV百度风投、杏泽资本、佳银资本持续跟投。值得关注的是，这是智冉医疗在半年内完成的第二轮融资，短时间内连续获得资本青睐，充分印证了市场对其在侵入式脑机接口赛道技术实力与发展潜力的双重认可。据悉，本轮所募资金将主要用于推进大规模临床试验与高通量柔性脑机接口产品迭代，加速该技术向临床应用落地。联想集团副总裁、联想创投管理合伙人王光熙表示，脑机接口作为硅基时代的核心前沿赛道，是人机共生未来的关键突破口。当前侵入式路线凭借高分辨率、高传输速率的优势，成为全球竞速的核心赛场。智冉医疗作为国内侵入式脑机接口的领军者，不仅攻克了柔性电极、神经芯片、解码算法等全链条核心技术，更率先完成了临床验证，展现了扎实的工程化与商业化能力。联想创投持续加注，正是看好智冉引领产业变革的潜力，我们将发挥CVC2.0生态优势，在技术研发、供应链协同与临床转化等方面深度赋能，助力智冉加速推进产品迭代与规模化落地，携手抢占全球脑机接口赛道先机。从创立之初，智冉就坚定地走侵入式脑机接口技术路线，一方面是因为团队在侵入式脑机接口底层技术拥有深厚的技术积累；另一方面，是基于对行业终局的深刻认知。脑机接口的未来是要实现人类大脑与外部设备之间高带宽的信息交互，从而将脑机接口从一种‘弥补缺陷’的辅助工具，进化为人类通往高效人机共生的核心底层技术，而只有侵入式脑机接口的路线能够实现这一跨越。半侵入式 VS 侵入式当前，植入式脑机接口已然形成了两种技术路线：半侵入式脑机接口和侵入式脑机接口。两者的本质区别在于电极与脑组织的物理位置关系，这直接决定了神经信号的质量与应用上限。半侵入式脑机接口通过将电极放置在硬膜上或者硬膜下采集大脑中的神经信号，由于神经信号随着传输距离迅速衰减，半侵入式脑机接口所采集信号的时间和空间分辨率较低，难以提取精细的神经编码信息；与之相比，侵入式脑机接口直接将柔性电极植入脑组织内部，从而能够精准捕获具有高时空间分辨率的单神经元动作电位（Spikes）。因此，侵入式脑机接口不仅能实现对精细动作的实时、高精度解码，更在人机交互的信息传输速率（Bit Rate）有数量级的优势。在侵入式脑机接口技术的全球竞争中，国外市场由马斯克创办的Neuralink率先领跑，国内则由智冉医疗凭借在核心技术领域的突破，叠加全链条自主创新优势，成为国产侵入式脑机接口的领军企业。成立至今，智冉医疗已完成侵入式脑机接口产业链上中游的系统化布局，构建起从核心技术研发到规模化量产的完整产业闭环：不仅攻克柔性电极、神经芯片、解码算法与电极植入机器人四大核心“底座”，更自建近2000㎡临床级微纳加工车间与GMP标准组装车间，实现临床级产品的全链条自主可控。其中，智冉高通量柔性电极近期迎来重大技术突破——公司创始人兼首席科学家方英领衔的科研团队，成功研制出兼具高通量信号采集与生物力学顺应性的“可拉伸高通量柔性电极”，一举破解传统线性柔性电极易移位、易脱出的行业难题。相关成果已于2月5日发表在国际学术期刊《自然・电子学》，并获《人民日报》、《科技日报》等权威媒体广泛关注。左：高通量可拉伸柔性电极；右：《自然・电子学》官网发布截图除此之外，智冉医疗还实现了其余关键技术底座的全面突破：其国产神经信号采集芯片仅有硬币大小，功耗较传统芯片直降75%；深度神经网络解码算法，依托海量神经元脑电数据进行训练，可实现高精度的实时解码；配套的高效率、高精度智能化电极植入机器人，则打通了高通量侵入式脑机接口技术大规模临床应用的“最后一公里”。目前，智冉医疗团队已成功研制出基于可拉伸柔性电极的高通量无线侵入式脑机接口系统，该系统通过优化脑机接口系统的生物相容性与信号传输的带宽，可有效提升信号的长期稳定性和解码精度，为侵入式脑机接口产品的规模化临床应用奠定了技术基础。临床进展2025年，智冉医疗已完成国内首例超百通道侵入式脑机接口产品的临床植入，初步验证了产品的安全性和有效性。据智冉医疗创始人、CEO宋麒透露：公司计划在今年（2026年）启动超百通道侵入式脑机接口产品的大规模注册临床，加速推进产品的临床落地。作为国产侵入式脑机接口领域的领军者，智冉医疗在脑机接口的发展精准呼应了国家“十五五”规划对未来产业的前瞻布局，其在核心技术上的突破，也响应了国家对前沿科技自主创新的要求，成为推动我国侵入式脑机接口技术跻身全球前列的重要力量。未来，公司将持续提速核心技术攻坚与临床转化进程，为我国脑机接口领域的自主创新注入强劲动能，助力中国在侵入式脑机接口赛道实现关键技术领跑。推荐阅读","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2610601380","isCrawlerRequest":true}